emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университет10.51922/2616-633X.2023.7.1.1828emcardio-63Research ArticleОригинальные научные публикацииOriginal Scientific ResearchДоклиническая кардиотоксичность при системном лечении резектабельного рака молочной железыPreclinical cardiotoxicity in systemic treatment of resectable breast cancerЧернякС. В.ChernyakS. V.

Минск

Minsk

КовшЕ. В.KovshYe. V.

Минск

Minsk

ЧерневскаяМ. В.ChernevskayaM. V.

Минск

Minsk

СеврукТ. В.SevrukT. V.

Минск

Minsk

ГорбатТ. В.GorbatT. V.

Минск

Minsk

РачокЛ. В.RachokL. V.

Минск

Minsk

АхмедН. Н.AkhmedN. N.

Минск

Minsk

ПавловаО. С.PavlovaO. S.

Минск

Minsk

olga.s_pavlova@yahoo.comГУ «Республиканский научно-практический центр «Кардиология»Republican Scientific and Practical Center of CardiologyУО «Белорусский государственный медицинский университет»Belarusian State Medical UniversityГУ «Республиканский научно-практический центр онкологии и медицинской радиологии им. Н.Н. Александрова»Republican Scientific and Practical Center of Oncology and Medical Radiology named after N.N. Alexandrov2023200620257118281834Copyright © Черняк С.В., Ковш Е.В., Черневская М.В., Севрук Т.В., Горбат Т.В., Рачок Л.В., Ахмед Н.Н., Павлова О.С., 20252025Черняк С.В., Ковш Е.В., Черневская М.В., Севрук Т.В., Горбат Т.В., Рачок Л.В., Ахмед Н.Н., Павлова О.С.Chernyak S.V., Kovsh Y.V., Chernevskaya M.V., Sevruk T.V., Gorbat T.V., Rachok L.V., Akhmed N.N., Pavlova O.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/63

Исследование онкологических пациентов с оценкой риска кардиотоксичности химиопрепаратов осуществлялось с использованием диагностических методов: эхокардиографии с оценкой глобальной деформации миокарда, магнитно-резонансной томографии сердца, анализа сердечных биомаркеров и жесткости артерий. Применение указанных методов позволило выявить субклиническое поражение сердца и сосудов у пациентов при системном лечении пациентов с резектабельным раком молочной железы.

Study of cancer patients and assessment of the cardiotoxicity risk of chemotoxic drugs has been performed using the following diagnostic methods: echocardiography with assessment of global myocardial deformation, cardiac magnetic resonance imaging, analysis of cardiac biomarkers and arterial stiffness. Application of the mentioned methods allowed to detect subclinical heart and vascular lesions before the appearance of clinical symptoms in patients resectable breast cancer and systemic treatment.

сердечно-сосудистые заболеваниякардиотоксичностьрак молочной железыглобальная продольная деформацияжесткость артерийсердечно-лодыжечный сосудистый индексскорость распространения пульсовой волныэкстрацеллюлярный объем левого желудочкаmyocardial infarctionheart failureradiation diagnostic methodsindex of microcirculatory resistanceReferencesChazova I.E., Ageev F.T., Aksenova A.V., Vitsenja M.V., Giljarov M.Ju., Martynjuk T.V., Panchenko E.P., Poltavskaja M.G., Potievskaja V.I., Trofimova O.P., Fedotkina Ju.A. Evrazijskie klinicheskie rekomendatsii po diagnostike, profilaktike i lecheniju serdechno-sosudistyh oslozhnenij pri protivoopuholevoj terapii [Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment]. Eurasian heart journal, 2022, vol. 37, no. 1. doi: 10.38109/2225-1685-2022-1-6-79 (in Russion).Chazova I.E., Ageev F.T., Aksenova A.V., Vitsenja M.V., Giljarov M.Ju., Martynjuk T.V., Panchenko E.P., Poltavskaja M.G., Potievskaja V.I., Trofimova O.P., Fedotkina Ju.A. Evrazijskie klinicheskie rekomendatsii po diagnostike, profilaktike i lecheniju serdechno-sosudistyh oslozhnenij pri protivoopuholevoj terapii [Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment]. Eurasian heart journal, 2022, vol. 37, no. 1. doi: 10.38109/2225-1685-2022-1-6-79 (in Russion).Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., Cutter D.J., de Azambuja E., de Boer R.A., Dent S.F., Farmakis D., Gevaert S.A., Gorog D.A., Herrmann J., Lenihan D., Moslehi J., Moura B., Salinger S.S., Stephens R., Suter T.M., Szmit S., Tamargo J., Thavendiranathan P., Tocchetti C.G., van der Meer P., van der Pal H.J.H.; ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J, 2022, vol. 43(41), pp. 4229-4361. doi: 10.1093/eurheartj/ehac244.Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., Cutter D.J., de Azambuja E., de Boer R.A., Dent S.F., Farmakis D., Gevaert S.A., Gorog D.A., Herrmann J., Lenihan D., Moslehi J., Moura B., Salinger S.S., Stephens R., Suter T.M., Szmit S., Tamargo J., Thavendiranathan P., Tocchetti C.G., van der Meer P., van der Pal H.J.H.; ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J, 2022, vol. 43(41), pp. 4229-4361. doi: 10.1093/eurheartj/ehac244.Curigliano G., Lenihan D., Fradley M., et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol, 2020, vol. 31, no. 2, pp. 171-190. doi: 10.1016/j.annonc.2019.10.023.Curigliano G., Lenihan D., Fradley M., et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol, 2020, vol. 31, no. 2, pp. 171-190. doi: 10.1016/j.annonc.2019.10.023.Papageorgiou C., Andrikopoulou A., Dimopoulos M.A., Zagouri F. Cardiovascular toxicity of breast cancer treatment: an update. Cancer Chemother Pharmacol, 2021, vol. 88(1), pp. 15-24. doi: 10.1007/s00280-021-04254-w.Papageorgiou C., Andrikopoulou A., Dimopoulos M.A., Zagouri F. Cardiovascular toxicity of breast cancer treatment: an update. Cancer Chemother Pharmacol, 2021, vol. 88(1), pp. 15-24. doi: 10.1007/s00280-021-04254-w.Ram P., Tiu A., Lo K. B., Parikh K., Shah M. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study. Heart Failure Reviews, 2019, vol. 24, no. 6, pp. 989-995. doi: 10.1007/s10741-019-09808-y.Ram P., Tiu A., Lo K. B., Parikh K., Shah M. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study. Heart Failure Reviews, 2019, vol. 24, no. 6, pp. 989-995. doi: 10.1007/s10741-019-09808-y.Larsen C.M., Mulvagh S.L. Cardio-oncology: what you need to know now for clinical practice and echocardiography. Echo Res Prat, 2017. vol. 4, no. 1, pp. 33-41. doi:10.1530/ERP-17-0013.Larsen C.M., Mulvagh S.L. Cardio-oncology: what you need to know now for clinical practice and echocardiography. Echo Res Prat, 2017. vol. 4, no. 1, pp. 33-41. doi:10.1530/ERP-17-0013.Fei H.W., Ali M.T., Tan T.C., et al. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction. Echocardiography, 2016, vol. 33, no. 4. pp. 519-26. doi:10.1111/echo.13168.Fei H.W., Ali M.T., Tan T.C., et al. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction. Echocardiography, 2016, vol. 33, no. 4. pp. 519-26. doi:10.1111/echo.13168.Calle M.C., Sandhu N.P., Xia H., et al. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer, 2018, vol. 18. doi:10.1186/ s12885-018-4935-z.Calle M.C., Sandhu N.P., Xia H., et al. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer, 2018, vol. 18. doi:10.1186/ s12885-018-4935-z.Tu C., Shen H., Liu R., Wang X., Li X., Yuan X., Chen Q., Wang Y., Ran Z., Lan X., Zhang X., Lin M., Zhang J. Myocardial extracellular volume derived from contrast-enhanced chest computed tomography for longitudinal evaluation of cardiotoxicity in patients with breast cancer treated with anthracyclines. Insights Imaging, 2022, vol. 13(1), pp. 85. doi: 10.1186/s13244-022-01224-5.Tu C., Shen H., Liu R., Wang X., Li X., Yuan X., Chen Q., Wang Y., Ran Z., Lan X., Zhang X., Lin M., Zhang J. Myocardial extracellular volume derived from contrast-enhanced chest computed tomography for longitudinal evaluation of cardiotoxicity in patients with breast cancer treated with anthracyclines. Insights Imaging, 2022, vol. 13(1), pp. 85. doi: 10.1186/s13244-022-01224-5.Souza C.A., Simões R., Borges K.B.G., Oliveira A.N., Zogeib J.B., Alves B., Malachias MVB, Drummond-Lage A.P., Rezende B.A. Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study. Arq Bras Cardiol, 2018, vol. 111, no. 5, pp.721-728. doi: 10.5935/abc.20180168.Souza C.A., Simões R., Borges K.B.G., Oliveira A.N., Zogeib J.B., Alves B., Malachias MVB, Drummond-Lage A.P., Rezende B.A. Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study. Arq Bras Cardiol, 2018, vol. 111, no. 5, pp.721-728. doi: 10.5935/abc.20180168.Parr SK, Liang J, Schadler KL, Gilchrist SC, Steele CC, Ade CJ. Anticancer Therapy-Related Increases in Arterial Stiffness: A Systematic Review and Meta-Analysis. J Am Heart Assoc, 2020, vol. 9(14), e015598. doi: 10.1161/JAHA.119.015598.Parr SK, Liang J, Schadler KL, Gilchrist SC, Steele CC, Ade CJ. Anticancer Therapy-Related Increases in Arterial Stiffness: A Systematic Review and Meta-Analysis. J Am Heart Assoc, 2020, vol. 9(14), e015598. doi: 10.1161/JAHA.119.015598.

The authors declare that there are no conflicts of interest present.